CARGO Therapeutics (CRGX) Financials

Balance sheets

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 202330 June 202301 Mar 202331 Dec 202201 Sept 2022

Total Assets

$451.0 M(-8.0%)$490.0 M(+16.0%)$422.4 M(-6.8%)$453.0 M(+449.7%)$82.4 M(+36.2%)$60.5 M-$10.2 M-

Current Assets

$410.0 M(-8.5%)$448.1 M(+17.9%)$379.9 M(-7.2%)$409.5 M(+545.7%)$63.4 M(+35.7%)$46.7 M-$3.9 M-

Non Current Assets

$40.9 M(-2.3%)$41.9 M(-1.3%)$42.5 M(-2.5%)$43.6 M(+129.3%)$19.0 M(+38.1%)$13.8 M-$6.3 M-

Total Liabilities

$50.1 M(-7.1%)$53.9 M(+9.5%)$49.2 M(+3.3%)$47.6 M(-75.2%)$191.7 M(+41.5%)$135.5 M-$45.5 M-

Current Liabilities

$21.6 M(-18.1%)$26.4 M(+16.7%)$22.6 M(+7.0%)$21.2 M(-48.5%)$41.1 M(+46.4%)$28.1 M-$44.1 M-

Long Term Liabilities

$28.4 M(+3.5%)$27.5 M(+3.5%)$26.6 M(+0.3%)$26.5 M(-82.4%)$150.6 M(+40.3%)$107.4 M-$1.3 M-

Shareholders Equity

$400.9 M(-8.1%)$436.1 M(+16.9%)$373.2 M(-7.9%)$405.4 M(+470.8%)-$109.3 M(-45.8%)-$75.0 M--$35.2 M-

Book Value

$400.9 M(-8.1%)$436.1 M(+16.9%)$373.2 M(-7.9%)$405.4 M(+470.8%)-$109.3 M(-45.8%)-$75.0 M--$35.2 M-

Working Capital

$388.4 M(-7.9%)$421.7 M(+18.0%)$357.3 M(-8.0%)$388.3 M(+1642.7%)$22.3 M(+19.6%)$18.6 M--$40.2 M-

Cash And Cash Equivalents

$71.2 M(-53.7%)$153.6 M(+88.4%)$81.5 M(-79.9%)$405.7 M(+572.4%)$60.3 M(+42.4%)$42.4 M-$1.9 M-

Accounts Payable

$5.4 M(-23.3%)$7.0 M(-2.3%)$7.2 M(+43.0%)$5.0 M(-32.5%)$7.4 M(+27.6%)$5.8 M-$3.5 M-

Accounts Receivable

---------

Short Term Debt

$143.0 K(-78.0%)$649.0 K(-60.4%)$1.6 M(-28.1%)$2.3 M(-12.1%)$2.6 M(+3.9%)$2.5 M-$22.9 M-

Long Term Debt

$28.4 M(+3.5%)$27.5 M(+3.5%)$26.6 M(+1.2%)$26.3 M(+8654.3%)$300.0 K(-69.3%)$978.0 K-$1.1 M-

Total Debt

$28.6 M(+1.6%)$28.1 M(-0.2%)$28.2 M(-1.2%)$28.5 M(+887.2%)$2.9 M(-16.8%)$3.5 M(+100.0%)$0.0(-100.0%)$24.0 M(+100.0%)$0.0

Debt To Equity

0.1(+16.7%)0.1(-25.0%)0.1(+14.3%)0.1(+333.3%)-0.0(+40.0%)-0.1--0.7-

Current Ratio

18.9(+11.7%)17.0(+1.1%)16.8(-13.3%)19.4(+1156.5%)1.5(-7.2%)1.7-0.1-

Quick Ratio

---------

Inventory

---------

Retained Earnings

-$267.2 M(-18.6%)-$225.3 M(-24.5%)-$181.0 M(-24.7%)-$145.1 M(-28.4%)-$113.1 M(-45.7%)-$77.6 M--$47.0 M-

PB Ratio

2.1(+22.5%)1.7(-26.4%)2.4(0%)2.4-----

Income statements

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 202330 June 202301 Mar 202331 Dec 202201 Sept 2022

EPS

-$0.9(+13.7%)-$1.0(-17.2%)-$0.9(-11.8%)-$0.8(+15.1%)-$0.9(-98.7%)-$0.5(-40.0%)-$0.3(+53.3%)-$0.7(-11.9%)-$0.6

TTM EPS

-$3.5(+1.0%)-$3.6(-18.4%)-$3.0(-21.7%)-$2.5(-3.0%)-$2.4(-13.4%)-$2.1(-27.7%)-$1.7(-24.6%)-$1.3(-111.9%)-$0.6

Revenue

---------

TTM Revenue

---------

Total Expenses

$47.1 M(-4.5%)$49.3 M(+20.9%)$40.8 M(+16.7%)$35.0 M(+21.8%)$28.7 M(+61.3%)$17.8 M(+16.7%)$15.2 M(+38.5%)$11.0 M(+9.5%)$10.0 M

Operating Expenses

$47.1 M(-4.5%)$49.3 M(+20.9%)$40.8 M(+16.7%)$35.0 M(+21.8%)$28.7 M(+61.3%)$17.8 M(+16.7%)$15.2 M(+38.5%)$11.0 M(+9.5%)$10.0 M

Cost Of Goods Sold

---------

TTM Cost Of Goods Sold

---------

Gross Profit

---------

TTM Gross Profit

---------

Gross Margin

---------

Operating Profit

-$47.1 M(+4.5%)-$49.3 M(-20.9%)-$40.8 M(-16.7%)-$35.0 M(-21.8%)-$28.7 M(-61.3%)-$17.8 M(-16.7%)-$15.2 M(-38.5%)-$11.0 M(-9.5%)-$10.0 M

TTM Operating Profit

-$172.2 M(-12.0%)-$153.8 M(-25.8%)-$122.3 M(-26.4%)-$96.7 M(-32.9%)-$72.8 M(-34.5%)-$54.1 M(-49.0%)-$36.3 M(-72.4%)-$21.1 M(-109.5%)-$10.0 M

Operating Margin

---------

Net Income

-$41.9 M(+5.5%)-$44.3 M(-23.8%)-$35.8 M(-11.6%)-$32.1 M(+9.6%)-$35.5 M(-98.7%)-$17.9 M(-40.0%)-$12.7 M(+7.3%)-$13.7 M(-11.9%)-$12.3 M

TTM Net Income

-$154.1 M(-4.4%)-$147.7 M(-21.9%)-$121.2 M(-23.5%)-$98.1 M(-23.0%)-$79.8 M(-40.9%)-$56.6 M(-46.0%)-$38.8 M(-49.0%)-$26.0 M(-111.9%)-$12.3 M

Net Margin

---------

EBIT

-$41.9 M(+5.5%)-$44.3 M(-23.8%)-$35.8 M(-11.6%)-$32.1 M(+9.6%)-$35.5 M(-98.7%)-$17.9 M(-60.2%)-$11.1 M(-0.9%)-$11.0 M(-2.0%)-$10.8 M

TTM EBIT

-$154.1 M(-4.4%)-$147.7 M(-21.9%)-$121.2 M(-25.6%)-$96.5 M(-27.9%)-$75.5 M(-48.5%)-$50.9 M(-54.1%)-$33.0 M(-51.0%)-$21.9 M(-102.0%)-$10.8 M

EBITDA

-$40.1 M(+5.1%)-$42.3 M(-24.5%)-$34.0 M(-9.6%)-$31.0 M(+10.0%)-$34.4 M(-102.6%)-$17.0 M(-62.5%)-$10.5 M(+1.4%)-$10.6 M(-1.4%)-$10.5 M

TTM EBITDA

-$147.3 M(-4.0%)-$141.6 M(-21.7%)-$116.3 M(-25.3%)-$92.9 M(-28.1%)-$72.5 M(-49.4%)-$48.5 M(-53.9%)-$31.5 M(-49.6%)-$21.1 M(-101.4%)-$10.5 M

Selling, General & Administrative Expenses

$11.2 M(-5.7%)$11.9 M(+15.1%)$10.3 M(+30.6%)$7.9 M(+21.8%)$6.5 M(+67.5%)$3.9 M(+44.0%)$2.7 M(+51.4%)$1.8 M(+12.3%)$1.6 M

TTM SG&A

$41.2 M(+12.9%)$36.5 M(+28.0%)$28.5 M(+36.4%)$20.9 M(+41.3%)$14.8 M(+49.4%)$9.9 M(+64.0%)$6.0 M(+80.0%)$3.4 M(+112.3%)$1.6 M

Depreciation And Amortization

$1.8 M(-13.9%)$2.1 M(+11.8%)$1.9 M(+68.4%)$1.1 M(+5.0%)$1.0 M(+22.1%)$859.0 K(+25.8%)$683.0 K-$1.0 M

TTM D&A

$6.8 M(+12.1%)$6.1 M(+25.0%)$4.9 M(+31.7%)$3.7 M(+42.5%)$2.6 M(+1.4%)$2.6 M(+50.6%)$1.7 M-$1.0 M

Interest Expense

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(-100.0%)$1.6 M(-40.8%)$2.7 M(+85.7%)$1.5 M

TTM Interest Expense

$0.0(0%)$0.0(0%)$0.0(-100.0%)$1.6 M(-62.8%)$4.3 M(-25.3%)$5.8 M(0%)$5.8 M(+38.5%)$4.2 M(+185.7%)$1.5 M

Income Tax

---------

TTM Income Tax

---------

PE Ratio

---------

PS Ratio

---------

Cashflow statements

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 202330 June 202301 Mar 202331 Dec 202201 Sept 2022

Cash From Operations

-$39.6 M(-12.9%)-$35.1 M(-16.4%)-$30.1 M(-4.0%)-$29.0 M(-24.8%)-$23.2 M(-55.8%)-$14.9 M(-6.0%)-$14.1 M--$17.7 M

TTM CFO

-$133.8 M(-14.0%)-$117.4 M(-20.8%)-$97.2 M(-19.8%)-$81.2 M(-55.5%)-$52.2 M(-11.8%)-$46.7 M(-46.9%)-$31.8 M--$17.7 M

Cash From Investing

-$43.2 M(-1239.1%)$3.8 M(+101.3%)-$294.0 M(-9784.2%)-$3.0 M(+23.8%)-$3.9 M(-161.4%)-$1.5 M(-141.4%)-$619.0 K--$2.3 M

TTM CFI

-$336.3 M(-13.2%)-$297.0 M(+1.8%)-$302.3 M(-3262.2%)-$9.0 M(-49.4%)-$6.0 M(-37.7%)-$4.4 M(-51.9%)-$2.9 M--$2.3 M

Cash From Financing

$402.0 K(-99.6%)$103.3 M(+99474.0%)-$104.0 K(-100.0%)$377.9 M(+738.0%)$45.1 M(+2254650.0%)$2000.0(-100.0%)$71.6 M-$21.5 M

TTM CFF

$481.6 M(-8.5%)$526.3 M(+24.4%)$422.9 M(-14.5%)$494.6 M(+323.9%)$116.7 M(+25.4%)$93.0 M(0%)$93.0 M-$21.5 M

Free Cash Flow

-$40.8 M(-10.2%)-$37.0 M(-16.6%)-$31.8 M(+0.6%)-$32.0 M(-17.8%)-$27.1 M(-65.4%)-$16.4 M(-11.7%)-$14.7 M--$20.0 M

TTM FCF

-$141.6 M(-10.7%)-$127.9 M(-19.3%)-$107.2 M(-18.9%)-$90.2 M(-54.9%)-$58.2 M(-14.0%)-$51.1 M(-47.3%)-$34.7 M--$20.0 M

CAPEX

---------

TTM CAPEX

---------

Dividends Paid

---------

TTM Dividends Paid

---------

TTM Dividend Per Share

---------

TTM Dividend Yield

---------

Payout Ratio

---------